Vaishali Pharma Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Vaishali Pharma Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
26.11% Fall from 52W High
7.4
TTM PE Ratio
High in industry
246.8
Price to Book Ratio
Below industry Median
4.1
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-2.8
RSI
RSI is mid-range
50.8
MFI
MFI is mid-range
60.5

Vaishali Pharma Ltd shareholding Pattern

Promoter
26.3%
Public
73.7%
Promoter
26.6%
Public
73.4%
Promoter
26.6%
Public
73.4%
Promoter
26.7%
Public
73.3%
Promoter
26.7%
Foreign Institutions
0.6%
Public
72.7%
Promoter
26.7%
Public
73.2%

Vaishali Pharma Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
8
Bearish Moving Averages
8
5Day EMA
149.70
10Day EMA
148.80
12Day EMA
148.70
20Day EMA
149.00
26Day EMA
149.70
50Day EMA
152.00
100Day EMA
153.70
200Day EMA
150.80
5Day SMA
149.30
10Day SMA
149.60
20Day SMA
145.90
30Day SMA
150.80
50Day SMA
154.80
100Day SMA
155.00
150Day SMA
158.90
200Day SMA
152.00
Delivery & Volume
Resistance & Support
150.90
Pivot
Resistance
First Resistance
154.49
Second Resistance
158.55
Third Resistance
162.14
Support
First Support
146.84
Second support
143.25
Third Support
139.19
Relative Strength Index
50.85
Money Flow Index
60.47
MACD
-1
MACD Signal
-2.14
Average True Range
7.22
Average Directional Index
16.99
Rate of Change (21)
-2.94
Rate of Change (125)
-20.36
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Bafna Pharmaceuticals Ltd.
-
-
-
Mangalam Drugs and Organics Ltd.
168.11
90.8
132.45
Krebs Biochemicals & Industries Ltd.
153.77
60.35
93.95
Pharmaids Pharmaceuticals Ltd.
-
-
-
Syschem (India) Ltd.
-
-
-
Sotac Pharmaceuticals Ltd
-
-
-

Vaishali Pharma Ltd Company background

Founded in: 2008
Managing director: Atul Vasani
Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name Vaishali Pharma Private Limited on 25th, April 2008. On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited. Subsequently, the Company converted into a Public Limited Company and the name was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the Promoters of the Company.Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the Company gets the formulations whose facilities are approved and certified by respective countries for developing the products. The Company has over 250 + formulation brands marketed in multiple countries of which dossier is in CTD format along with itsrespective bioequivalence. The Company built a robust pipeline of around 250 Dossiers. The Companys synergistic collaboration with WHOGMP manufacturing facilities is backed by an excellent rapport with clients.In 2012, the Company ventured into new Vertical in Formulation Manufacturing and Exports. In 2016, it introduced a vertical of Surgical Division. The Company obtained ISO 9001:2015 Certification for the Quality Management System from Deutsche Accreditation Board, Germany and ISC Global, Dubai, UAE. It is also certified by European Certification Organisation and Compliance Certificate with regards to Council Directive relating to Surgical Instruments Medical Devices Directive. In addition, the Company has also been recognized by Government of India as One Star Export House and holds a valid certificate for the same from the Director General of Foreign Trade in 2017. In August 2017, Company came up with an Initial Public Offer consisting of Fresh Issue of 19,76,000 Equity Shares by raising capital aggregating Rs 14.22 Crore.
Read More

Vaishali Pharma Ltd FAQs

The past 1-year return of Vaishali Pharma Ltd [VAISHALI] share was 19.2. The Vaishali Pharma Ltd [VAISHALI] share hit a 1-year low of Rs. 114.85 and a 1-year high of Rs. 203.6.

The market cap of Vaishali Pharma Ltd is Rs. 161.26 Cr. as of 6/20/2024 12:00:00 AM.

The PE ratios of Vaishali Pharma Ltd is 224.54 as of 6/20/2024 12:00:00 AM.

The PB ratios of Vaishali Pharma Ltd is 3.76 as of 6/20/2024 12:00:00 AM

You can easily buy Vaishali Pharma Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage